SCHEMBL2064403

SCHEMBL2064403

CN(C)S(=O)(=O)c1cccc(-c2cn3cc(-c4cccc(F)c4CO)ccc3n2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
HPGD P15428 4/20 0.62
GFER P55789 3/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HSD17B10 Q99714 2/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
TP53 P04637 1/20 0.62
TSHR P16473 1/20 0.62
KDM4E B2RXH2 8/20 0.60
LMNA P02545 1/20 0.52
NR4A2 P43354 5/20 0.48
GAA P10253 2/20 0.48
RXFP1 Q9HBX9 2/20 0.48
GLA P06280 1/20 0.48
MAPK1 P28482 1/20 0.48
TRPV3 Q8NET8 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2064165 0.91 ALDH1A1 (0.61) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL2063556 0.82 NR4A2 (0.55) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL2064109 0.81 NR4A2 (0.60) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL2064448 0.81 NR4A2 (0.60) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL2065198 0.81 NR4A2 (0.63) ALDH1A1HPGDKMT2AHSD17B10NPC1
SCHEMBL2063397 0.80 NR4A2 (0.48) ALDH1A1HPGDNPC1RAB9AKDM4E
SCHEMBL2063617 0.80 NR4A2 (0.54) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL2064088 0.80 NR4A2 (0.61) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL3432775 0.80 NR4A2 (0.58) ALDH1A1NPC1RAB9AKDM4ELMNA
SCHEMBL2063554 0.80 ALDH1A3 (0.65) ALDH1A1HPGDNPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP claimed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US claimed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US claimed
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP disclosed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US disclosed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN ALDH1A1 193/4885HPGD 2181/4885GFER 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.